Aurora (TSX:ACB) Stock Dipped Below $5 and Is Too Cheap to Ignore!

Aurora Cannabis shows precisely how severe the year has been for pot stocks. Approaching an all-time low, let us see if you should still consider the stock.

| More on:

Aurora Cannabis (TSX:ACB)(NYSE:ACB) shares present a picture of how bad 2019 was for the entire legal marijuana industry in Canada. From reaching remarkable highs of $13.71 towards October 2018, it took ACB very little time to drop to half its value and go down to $6.67 by the end of December.

Things started looking up for the pot stock, as ACB climbed up to $12.83 in March 2019. Much like most of the significant pot companies, the second-largest Canada-based cannabis producer had a lot of growth potential. Similarly, the now $4.96 billion market capitalization company could not deliver profitability, which reflected the promise.

It is safe to say that analysts and investors alike are wary of the overall legal marijuana industry, and Aurora Cannabis is no exception. ACB saw a steep drop in value from its 52-week high from March 15, 2019, to lose 62.43% and come down to the current price of $4.82 a share. The question is, does the below $5 valuation make ACB a good buy?

Growers causing growers problems

A significant reason why the wider legal marijuana industry could not deliver profitability is owing to the illegal pot industry. Illegal growers have to worry about little more than the costs of growth and distribution. Legal producers have a slew of expenses to worry about, and on top of that, they face regulatory restrictions and quality standards.

The costs these companies face end up affecting the prices of products that end consumers buy. The demand for recreational marijuana is high, but many consumers prefer to buy cheaper products from illegal growers. Beyond the unfair competition to meet demand, scandals riddling the industry also drive a lot of potential customers away, making life tougher.

More promises

With Cannabis 2.0, Canada passed another wave of laws legalizing further cannabis-related products, such as vapes, concentrates, and edibles. The market for these products presents a better future for pot producers since they entail higher profit margins for the significant pot companies. The announcement was as recent as October 17, 2019, and these products will not be available for retail until at least mid-December.

Aurora Cannabis is among the several companies eyeing Cannabis 2.0 as an opportunity to make right on its promises. The company plans to use this as a means to reach better valuations and sustain robust growth in revenue.

Terry Booth, Aurora’s CEO, stated that the company has made industry-leading capacity to produce cannabis. He claims that ACB’s consumer research and retail distribution bench strength will help the company launch the next-gen cannabis products in the Canadian markets. Aurora has plans to leverage the broader market opened up by Cannabis 2.0.

Foolish takeaway

I have said it before, and I will repeat it: ACB has a lot of potential for growth. The introduction of next-generation products, courtesy of Cannabis 2.0, could likely present Aurora the adrenaline shot that the company needed. However, as I also said, pot companies are struggling to compete with the illegal weed market.

If you are interested in cannabis stocks, I believe that taking a little bit of risk and placing your faith in Aurora could turn out to be great. I would not, however, suggest investing more than what you are willing to lose.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Adam Othman has no position in any of the stocks mentioned.

More on Cannabis Stocks

Cannabis business and marijuana industry concept as the shadow of a dollar sign on a group of leaves
Cannabis Stocks

Should You Buy Canopy Growth Stock or Green Thumb Stock Today?

Let's dive into two cannabis giants, and which one may be the better pick for long-term investors.

Read more »

Farmer smiles near cannabis crop
Cannabis Stocks

Could Aurora Cannabis Stock Finally Recover by Year-End?

Down 99% from all-time highs, Aurora Cannabis stock is focused on improving profit margins and expanding sales of its medical…

Read more »

Farmer smiles near cannabis crop
Cannabis Stocks

Are Pot Stocks About to Surge Again? 

With pot stocks making big moves of late, many investors are now asking whether the cannabis sector is worth investing…

Read more »

Farmer smiles near cannabis crop
Cannabis Stocks

Can Pot Stocks Aurora Cannabis and Canopy Growth Bounce Back in Q4?

Down over 99% from all-time highs, Canadian pot stocks such as Aurora Cannabis and Canopy Growth remain high-risk bets.

Read more »

Worker tags plants at an industrial cannabis operation
Cannabis Stocks

Can Canopy Growth Stock Finally Recover in 2024?

Down 98% from all-time highs, Canopy Growth remains a high-risk investment in 2024 given its weak fundamentals.

Read more »

Tech Stocks

3 No-Brainer Stocks to Buy With $20 Right Now

These three stocks are easy buys for those who don't have all that much to spend, and want long-term growth…

Read more »

Pot stocks are a riskier investment
Cannabis Stocks

Slow Burn: Is Aurora Cannabis Finally a Good Buy in June?

One of the benefits of choosing from some of the most beaten-down market segments like cannabis is that even a…

Read more »

Caution, careful
Cannabis Stocks

I Wouldn’t Touch This TSX Stock With a 60-Foot Pole

I wouldn't touch Canopy Growth Corp (TSX:WEED) stock with a 60-foot pole.

Read more »